XOMA Corporation (XOMA)
NASDAQ: XOMA · IEX Real-Time Price · USD
27.94
-0.12 (-0.43%)
Jul 22, 2024, 10:06 AM EDT - Market open
XOMA Corporation Employees
XOMA Corporation had 13 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$447,000
Profits / Employee
-$3,468,077
Market Cap
325.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Zynex | 1,100 |
Spok Holdings | 384 |
Kamada | 378 |
Amarin Corporation | 275 |
ADC Therapeutics | 274 |
Nautilus Biotechnology | 167 |
Foghorn Therapeutics | 116 |
XOMA News
- 4 weeks ago - XOMA Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 5 weeks ago - XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher - GlobeNewsWire
- 6 weeks ago - LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License - Business Wire
- 2 months ago - XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities - GlobeNewsWire
- 3 months ago - XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) - GlobeNewsWire
- 3 months ago - Actym Therapeutics Appoints Thomas Smart as CEO - PRNewsWire
- 3 months ago - XOMA Corporation Announces Closing of Tender Offer - GlobeNewsWire